BPC-157 and TB500 are therapeutic peptides that work synergistically to support the body's natural recovery and repair processes. BPC-157, often referred to as the "Body Protection Compound" is a peptide derived from gastric juices and is believed to play a role in maintaining tissue health and supporting the body's natural repair mechanisms for muscles, tendons, ligaments, and the gastrointestinal lining. TB500, a synthetic version of thymosin beta-4, complements these effects by supporting healthy inflammation responses, promoting cellular migration, and aiding in tissue regeneration.

When combined, these peptides are thought to enhance each other's properties, offering targeted support for recovery and tissue health. Commonly sought after by individuals aiming to maintain an active lifestyle, optimize their recovery after physical exertion, or support general tissue integrity, this peptide combination provides a comprehensive approach to wellness.

BPC-157/TB500 may be beneficial for individuals seeking to support tissue repair, reduce inflammation, and enhance recovery under the guidance of a qualified healthcare provider. People recovering from injuries, such as muscle strains, ligament sprains, or joint damage, may find these peptides helpful due to their ability to promote healing and tissue regeneration. Additionally, BPC-157/TB500 may provide support for individuals with chronic inflammatory conditions, such as arthritis or tendinitis, by addressing the underlying inflammation and encouraging tissue repair.

These peptides may also assist individuals recovering from surgical procedures by potentially accelerating healing and minimizing scarring. Furthermore, BPC-157's role in protecting and repairing the gastrointestinal lining could be particularly valuable for those with gut-related conditions, such as leaky gut or inflammatory bowel disease (IBD). Athletes or physically active individuals may use these peptides to optimize performance and recovery, although use should always comply with regulatory guidelines and medical oversight. It is important to note that BPC-157/TB500 is not FDA-approved for any specific medical condition and should only be used when prescribed and dispensed by a licensed healthcare provider through a 503A compounding pharmacy in compliance with all applicable laws and regulations.

• Each order includes two (2) 5ml vials of BPC-157/TB500, with a concentration of 3mg/mL of BPC-157 and 3mg/mL of TB500 (3mg/3mg/mL), providing a total of 15mg in each bottle and 30mg total. When taken at the recommended dose of .6 mg (20 units) Monday-Friday, the supply is designed to last approximately 8 weeks. Please follow the dosing instructions provided by your healthcare provider to ensure optimal use and effectiveness.

• The suggested protocol for administering BPC-157/TB500 is .6mg (20 units) Monday-Friday, for a total of 3 mg per week. Always follow the guidance of your healthcare provider to determine the best dosage and frequency for your specific needs.

BPC-157/TB500 injections are typically administered subcutaneously, with common injection sites including the thigh (vastus lateralis) or the fatty part of arm or abdomen. Always follow the instructions provided by your healthcare provider or the detailed guidelines included with your medication to ensure safe and proper administration. If you are unfamiliar with intramuscular injections, consult a healthcare professional for guidance or assistance.

BPC-157/TB500 is a compounded peptide that should only be used under the supervision of a licensed healthcare provider. While early research suggests potential benefits, it is not FDA-approved, and its use may not be appropriate for everyone. Individuals with the following conditions or circumstances should not use BPC-157/TB500 unless specifically directed by a qualified medical professional. Always consult your primary care physician before starting this or any new medication to ensure it is safe and appropriate for your individual health needs:

1. Active Cancer or Tumors - Since BPC-157 and TB500 promote angiogenesis (the formation of new blood vessels), there is concern that they could accelerate tumor growth. Patients with active cancer or a history of cancer should consult an oncologist before considering peptide therapy.
2. Pregnancy or Breastfeeding - There is insufficient research on the safety of these peptides for pregnant or breastfeeding individuals. As a precaution, BPC-157/TB500 should not be used during pregnancy or lactation.
3. Active Infections - Since BPC-157 and TB500 modulate the immune system, they may alter the body's natural response to infections. Individuals with acute bacterial, viral, or fungal infections should avoid use until the infection is resolved.
4. Severe Liver or Kidney Disease - Because peptides are metabolized by the liver and excreted by the kidneys, individuals with significant liver or kidney impairment should avoid use or undergo close monitoring by their healthcare provider.
5. Blood Clotting Disorders or Use of Blood Thinners - BPC-157 has potential effects on blood vessel repair, and its interaction with anticoagulants or individuals with clotting disorders is not well understood. Patients on medications like warfarin, heparin, or direct oral anticoagulants should consult a medical professional before use.
6. Autoimmune Disorders or Immunosuppressive Therapy - While BPC-157 may have immune-modulating properties, its effects on individuals with autoimmune diseases (e.g., lupus, rheumatoid arthritis) or those taking immunosuppressive medications are not fully established. Use in these cases should be carefully evaluated by a specialist.
7. Pediatric Patients (Under 18 Years Old) - There is limited clinical data on the safety and efficacy of BPC-157/TB500 in children or adolescents, so its use in this population is generally not recommended unless prescribed by a healthcare provider with expertise in pediatric peptide therapy.

Important Disclaimer:
BPC-157/TB500 is not FDA-approved for the treatment, prevention, or cure of any disease. All use must comply with guidance from a licensed healthcare professional and be dispensed by a 503A compounding pharmacy in accordance with regulatory standards. Patients should discuss potential risks and benefits with their provider to determine if peptide therapy is appropriate for their specific health needs.

BPC-157/TB500 is generally well-tolerated when used under the supervision of a healthcare provider; however, like any injectable therapy, some individuals may experience side effects. The most commonly reported side effects include mild injection site reactions, such as redness, swelling, or irritation, which typically resolve on their own. Some users have also reported temporary dizziness, nausea, or changes in appetite, though these effects are generally mild and short-lived.

Less commonly, some individuals may experience mild digestive discomfort or fatigue, but these effects are typically transient. Since BPC-157 and TB500 influence tissue repair and angiogenesis, there is theoretical concern about potential interactions with existing health conditions, such as abnormal blood clotting or unregulated cell growth. However, long-term safety data in humans is still limited, and ongoing research is needed to fully understand all potential effects.

Important Disclaimer:
BPC-157/TB500 is not FDA-approved for the treatment or prevention of any medical condition. It should only be used when prescribed by a licensed healthcare provider and dispensed by a 503A compounding pharmacy in compliance with regulatory standards. If you experience any unexpected or concerning side effects, discontinue use and consult your healthcare provider immediately.

Yes, BPC-157/TB500 can be used alongside GLP-1 receptor agonists (e.g., GLP-1 + B12, GLP-1/GIP + B12) under the supervision of a healthcare provider. While BPC-157/TB500 supports tissue repair and recovery, GLP-1s aid in metabolic health and weight management, potentially complementing each other's effects. However, combining peptides should be done with medical guidance to ensure proper dosing, monitor for side effects, and avoid unintended interactions.

Yes! Your prescription will include alcohol wipes, syringes, and everything you need to get started on your wellness journey.

Yes, while a medical professional will review your profile before prescribing, it's crucial to consult your primary care provider, who is familiar with your full medical history, to ensure comprehensive and personalized care. Your doctor can provide insights into your overall health that might not be available through our service.